Document is current
Any future updates will be listed below
-
Authors
Valerio, Cynthia M.
Saraiva, Jose F. K.
Valente, Fernando
van de Sande-Lee, Simone
Rocha, Viviane Z.
Rached, Fabiana H.
Drager, Luciano F.
Halpern, Bruno
Júnior, Wellington S. Silva
Trujilho, Fabio R.
Dornelas, Neuton
da Silva Filho, Ruy Lyra
Salles, João Eduardo N.
Assad, Marcelo H. V.
Mancini, Marcio C.
Miranda, Paulo A. C.
Moreira, Rodrigo
Lamounier, Rodrigo N.
Kaiser, Sergio
Bertoluci, Marcello C.
- License Information
-
More Information
Article History
Received: 15 August 2025
Accepted: 12 September 2025
First Online: 18 November 2025
Declarations
:
: Not applicable.
: Not applicable.
: CMV has received speaker and consultancy fees from Chiesi Pharmaceuticals, Eli Lilly, Merck, BI-Lilly, EMS, Abbvie and Novo Nordisk.JFKS has received speaker and consultancy fees from Astra Zeneca. Lilly, Novo Nordisk, Mantecorp, Bayer, Novartis, Daichii Sankyo, Boehringer Ingelheim, and MSD.FV has received speaker and consultancy fees from Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly, EMS, GSK, and Novo Nordisk.SvLS has received speaker and consultancy fees from Abbott, Lilly, and Merck e Novo Nordisk.VZR has received speaker and consultancy fees Abbott, Aché, Daichii-Sankyo, Lilly, Novo Nordisk, Novartis, and Ultragenyx.FHR has received speaker and consultancy fees from Novartis, Novo Nordisk, and Daichii Sankyo.LFD has received speaker and consultancy fees from Lilly, Novo Nordisk, Astrazeneca, Boehringer, and ResMed.BH has received speaker and consultancy fees from Novo Nordisk, Lilly, Boehringer Ingelheim, Astra Zeneca, Merck, and Novartis.WSSJ has received speaker and consultancy fees from Abbott, AstraZeneca, Brace Pharma, Libbs, Lilly, Novartis, Novo Nordisk, and Roche.FRT has received speaker and consultancy fees from Aché, AstraZeneca, Chiesi, BracePharma, Boehringer Ingelheim and Eli Lilly do Brasil, EMS, Eurofarma, Johnson & Johnson, Myrallis, Merck, Novo Nordisk, Servier, Scitech Medical, and Takeda.ND has received speaker and consultancy fees from Novo Nordisk.RLSF has received speaker and consultancy fees from Astra Zeneca. Lilly, Novo Nordisk, Boheringer, Mantecorp, Biolab, Brace Farma, EMS and Eurofarma.JENS has received speaker and consultancy fees from Astrazeneca, Bayer, Boehringer-Ingelheim, Lilly, Merck serono, and Novo Nordisk.MHVA has received speaker and consultancy fees from Astrazeneca, Bayer, Biolab, Daiichi Sankyo, EMS, GSK, Novartis, Novo Nordisk, and Lilly.MM has received speaker and consultancy fees from Lilly, Merck, EMS, Eurofarma, Myralis, and Brace Farma.PACM has received speaker and consultancy fees from NovoNordisk, Lilly, Recordat, Ache, and Ipsen.ROM has received speaker and consultancy fees from Astra-Zeneca, Merck, Bayer, Libbs, EMC, Brace Pharma, Servier, PTC, Lilly, and NovoNordisk.RNL has received speaker and consultancy fees from Abbott, Astra Zeneca, Eli Lilly, Medtronic, and Novo Nordisk.SK has received speaker and consultancy fees from Bayer, Biolab, Novo Nordisk, Novartis, Astrazeneca, Farmoquimica, and Daiichi Sankyo.MCB has received speaker and consultancy fees from Amgen, Bayer, Daiichi Sankyo, Eli-Lilly, Astrazeneca and Novo Nordisk.
